Relievant Medsystems raises $36m

October 11, 2016 By Fink Densford Leave a Comment

Relievant Medsystems said today that it raised a $36 million equity round to support clinical trials for its Intracept intraosseous nerve ablation system.

The Intracept system is designed to use radio frequency energy delivered through specially designed instruments during a minimally invasive surgical procedure to access and ablate the basivertebral nerve.

The company touts the system as the 1st specific therapy to relieve chronic lower back pain which has persisted for at least 6 months and not responded to conservative care during the time, which is caused by changes associated with degeneration of spinal vertebral bodies.

“We are proud to have our venture investment partners bolster our efforts to bring the novel Intracept therapy to the millions of patients suffering from CLBP and establish Intracept as a franchise opportunity in the marketplace. This capital will enable Relievant to accelerate execution of our product, clinical and market development activities to advance intraosseous basivertebral nerve ablation for CLBP ahead of successfully commercializing Intracept worldwide,” Relievant president & CEO Alex DiNello said in a press release.

The round was led by New Enterprise Assoc. and joined by Canaan Partners, Emergent Medical Partners and Morgenthaler Ventures, Relievant said.

“NEA is excited to continue its partnership with Relievant in bringing a game-changing technology to the millions of people who suffer from chronic low back pain. The robust Level 1 Smart clinical trial results demonstrate the Intracept system to be a safe, effective, durable and minimally invasive procedure that addresses a multi-billion dollar growth market. We believe the company’s dedication to demonstrating the benefits of Intracept through additional clinical development – working in close partnership with its clinical advisors, key societies and the payor community – is exactly the right approach to providing a therapy that addresses the needs of patients, spine surgeons and interventionalists, and payors,” NEA partner Dr. Justin Klein said in prepared remarks.

Funds raised in the round will help support additional clinical studies of the Intracept system, expanding the company’s product portfolio, accelerating commercial activities including “strategic initiatives with medicare contractors and third-party private payors,” the Redwood City, Calif.-based company said.

Relievant won FDA 510(k) clearance for the Intracept system in July, with indications for the treatment of chronic lower back pain.

The clearance came supported by the company’s 225-patient Smart study, which reported a mean improvement on the Oswestry Disability Index of 20.5 points, or 48%, from the baseline at 3 months, meeting the primary endpoint of the study.

Could these DIY ventilators stop coronavirus from killing people?
Amid the global crisis caused by the coronavirus pandemic, hospitals and healthcare facilities are reporting shortages of vital equipment that not only keeps the patients safe, but the staffers, too. One of the important devices for which demand has ramped up is ventilators for patients who need assistance with their breathing due to the respiratory… […]
DIY ventilators? Not unless there’s a zombie apocalypse.
News reports of the COVID-19 virus have given a lot of space to the shortage of respiratory ventilators. The Society of Critical Care Medicine claims at least 950,000 U.S. patients could need ventilators but hospitals only have 160,000. One response to statistics like these has been a movement among open-source promoters to initiate community-designed ventilators… […]
FDA announces EUAs related to ventilators to treat coronavirus
Amid a shortage of ventilators for treating coronavirus, the FDA put out a statement confirming its stance on issuing emergency use authorizations for potential temporary fixes. The FDA said it is operating on the basis of a EUA determination that the U.S. Dept. of Health and Human Services issues on Feb. 4. Earlier this week, HHS declared… […]
Hack the Crisis: Life-saving pneumatics from Emerson’s ASCO and Aventics
As the United States continues to focus on social distancing to combat COVID-19, more companies are revealing how the move home for their workers is impacting their business. Despite this, companies like Emerson’s ASCO and Aventics divisions continue to step up production on key technologies used in life sciences and laboratories, including ventilators, respirators, hospital… […]
Sterigenics gets 21-day reprieve to sterilize PPE in Georgia
Sterigenics may reopen its Atlanta medtech sterilization plant for 21 days to sterilize personal protective equipment (PPE) needed by healthcare workers during the COVID-19 pandemic. Cobb County officials announced the decision to allow the temporary reopening last night based on the county’s COVID-19 emergency declaration and conditional state approval of the results of negative-pressure air… […]
How instrumentation can help mass screen for fevers in COVID-19 cases
Kiran Unni, VP Industrials America, Frost & Sullivan Pandemic used to be a word one looked up in the dictionary (or the encyclopedia, in another era) as a purely academic exercise. Recent weeks and COVID-19 have shown us how it is now a clear and present danger on global, regional, state-wide and individual levels. Change in… […]
European Commission to ask for EU MDR enforcement delay
The European Commission is putting together a proposal to ask the European Parliament and Council to delay enforcement of the new Medical Device Regulation (EU MDR) by one year in light of the coronavirus pandemic. Medical device companies have been scrambling to meet the implementation of the new MDR, scheduled for May 26. (The in… […]
Kyocera acquires Showa Optronics
Kyocera today said it is acquiring Showa Optronics from NEC Corporation for an undisclosed amount. Through the acquisition, Kyocera will own 93.53% of Showa Optronics’s shares. Showa Optronics will operate as a subsidiary of Kyocera starting June 1 under the name Kyocera Showa Optronics. Showa Optronics manufactures semiconductors and medical equipment for DNA analysis using… […]
Factory CRO Group rebrands as Avania
Medtech contract research organization Factory-CRO Group is changing its name to Avania. Formed from Boston-based Boston Biomedical Associates (Marlborough, Mass.), Factory CRO (Bilthoven, Netherlands), Five Corners (Artarmon, Australia), and MileStone Research Organization (San Diego), Avania said it brings together regional teams of experts across a wide range of therapeutic specialties, including medical devices, novel technology… […]
Jefferies offers $10 million to jumpstart emergency drug packaging initiative
Jefferies Financial Group announced today that it is the first private-sector company to support a newly established public-private consortium launched by the U.S. Dept. of Health & Human Services (HHS). HHS launched the program last week, announcing that it joined with ApiJect Systems America to create a high-volume “surge” drug packaging solution in the U.S. by using… […]
ASTM provides free access to protective equipment standards
Global standards organization ASTM International announced today that it is providing no-cost public access to a suite of two dozen standards used in the production and testing of personal protective equipment (PPE) to combat the COVID-19 virus. Covered PPE includes face masks, medical gowns, gloves and hand sanitizers. The suite of available standards include test… […]